About

Publications While At HealthPartners

Highlights

selected publications

Journal Article

Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial. 

Nature Medicine. 2026

Impact of comorbidities on clinical outcomes and quality of life of patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer treated with Palbociclib in the POLARIS Study. 

Cancer medicine. 2026

OPERA: a phase II study of DHP107 (oral paclitaxel) versus intravenous paclitaxel in patients with HER2-negative recurrent or metastatic breast cancer. 

Breast Cancer Research and Treatment. 2026

Enhancing the interpretation of real-world quality of life in patients with HR+/HER2- advanced breast cancer enrolled in the POLARIS study. 

The oncologist. 2025

Real-world quality-of-life of patients with HR+/HER2- advanced breast cancer treated with palbociclib plus endocrine therapy: EORTC QLQ-C30 results from POLARIS. 

Breast Cancer Research and Treatment. 2025

Relationship of prior anticancer treatments with palbociclib clinical outcomes in patients with HR(+)/HER2(-) advanced breast cancer in real-world settings. 

Targeted Oncology. 2025

The combination of PAC-1 and entrectinib for the treatment of metastatic uveal melanoma. 

Melanoma Research. 2023

Blood outgrowth endothelial cells as a cellular carrier for oncolytic vesicular stomatitis virus expressing Interferon-β in preclinical models of non-small cell lung cancer. 

Translational Oncology. 2020

Review

Intracranial atherosclerosis disease associated with cognitive impairment and dementia: systematic review and meta-analysis [systematic review]. 

Journal of the American Heart Association. 2023

Contact

full name

Y. Ji

Quick Info

Publications

Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.

Collaboration

Co-author network

Map of science